EUVIMEDEUVIMED entdecken
Querschnittstudie

Serum Uric Acid in Type II Diabetes Mellitus Patients: A Cross-Sectional Study from a Tertiary Care Hospital, Gujarat

Riyaben P. Trivedi, Riddhi C. Patel, Sarvatnida N. Shaikh, Pradip K. Trivedi, Jay P. Patel

International Journal of Current Pharmaceutical Review and Research · 05.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.3 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 05.03.2026. Verfasst von Riyaben P. Trivedi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated with significant morbidity through micro- and macrovascular complications. Serum uric acid (SUA) has emerged as a potential biomarker linked to glycaemic dysregulation, dyslipidaemia, and early renal impairment. Despite its clinical relevance, SUA levels in T2DM patients remain understudied in the Indian context, particularly in Gujarat. Materials and Methods: A cross-sectional study was conducted at a tertiary care hospital, Pramukh Swami Medical College, Karamsad, and enrolling 200 participants: 100 T2DM patients and 100 age-sex–matched healthy controls. Biochemical parameters including fasting plasma glucose (FPG), HbA1c, serum uric acid, lipid profile, serum creatinine, and urine albumin-to-creatinine ratio (UACR) were measured. Statistical analysis was performed using Epi info version 7.

Results

Serum uric acid was significantly elevated in T2DM patients (6.43 ± 1.19 mg/dL) compared to controls (4.84 ± 0.99 mg/dL; p6.2 mg/dL as the optimal cut-off for predicting albuminuria (AUC=0.76; sensitivity 72%, specificity 68%).

Conclusion

Serum uric acid is significantly elevated in T2DM patients and independently correlates with atherogenic dyslipidaemia and early renal damage. Routine SUA monitoring may serve as an accessible and costeffective biomarker for cardiorenal risk stratification in diabetic populations.

Zitieren

APA

Trivedi, R. P., Patel, R. C., Shaikh, S. N., Trivedi, P. K., & Patel, J. P. (2026). Serum Uric Acid in Type II Diabetes Mellitus Patients: A Cross-Sectional Study from a Tertiary Care Hospital, Gujarat. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.3

Vancouver

Trivedi RP, Patel RC, Shaikh SN, Trivedi PK, Patel JP. Serum Uric Acid in Type II Diabetes Mellitus Patients: A Cross-Sectional Study from a Tertiary Care Hospital, Gujarat. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.3

BibTeX
@article{Trivedi2026,
  author = {Trivedi, Riyaben P. and Patel, Riddhi C. and Shaikh, Sarvatnida N. and Trivedi, Pradip K. and Patel, Jay P.},
  title = {Serum Uric Acid in Type II Diabetes Mellitus Patients: A Cross-Sectional Study from a Tertiary Care Hospital, Gujarat},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.3}
}
Kostenlos starten →